Why Amphenol Corporation (APH) stock moved
Amphenol Corporation (APH) shares fell 2.5% to $85.32 as of October 8, 2026, a moderate decline from the prior close of $87.55. BestStocks flagged the session as a major change for APH. The move is tied to a new SEC filing. Below, we break down what changed for APH, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
SEC Filing
APH fell 2.5% in its latest session, moving from $87.55 to $85.32.
What it means for Amphenol Corporation investors
For Amphenol Corporation investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Positive price momentum; Positive price momentum. Weighing against that: Negative session, down 2.5%; APH fell 4.41% to $142.69 ahead of Q2 earnings scheduled for July 29, driven by pre-earnings caution and profit-taking, according to the web synthesis. Wall Street's consensus price target sits at $144.57, implying +69.4% upside from $85.32. BestStocks rates the overall signal quality low (56/100). With earnings roughly 20 days out, the next report is the most likely near-term test of the move.
APH price reaction
APH last traded at $85.32, down $2.23 (-2.55%) from the previous close of $87.55. The session traded on 1.3× average volume (normal), so participation was unremarkable. Over the past month the stock has ranged between $77.26 and $88.62, and it currently sits about 71% of the way up that band.
Bullish and bearish analyst opinions on Amphenol Corporation (APH)
The consensus analyst price target on Amphenol Corporation (APH) is $144.57, 69.4% above the recent $85.32. Over the past 90 days analysts logged 0 upgrades, 12 maintains, and 0 downgrades. Here is how the bullish and bearish cases on APH line up.
The bullish case
- Wall Street's consensus price target of $144.57 implies +69.4% upside from $85.32.
- The Street's most bullish target is $215.00 (+152.0%).
- Positive price momentum.
- Amphenol Corporation moved +5.95% from $166.42 to $176.32 on 2026-06-30, reaching a new 30-day high.
The bearish case
- Negative session, down 2.5%.
- APH fell 4.41% to $142.69 ahead of Q2 earnings scheduled for July 29, driven by pre-earnings caution and profit-taking, according to the web synthesis.
- APH fell 5.58% to $162.61 intraday despite a July 2 Investors.com article noting the stock was trading around a buy-zone entry point alongside other Dow components.
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Oct 8, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for APH
In-depth APH event analyses
Frequently asked questions about APH
Why did Amphenol Corporation (APH) stock move?
APH fell 2.5% to $85.32. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did APH stock fall?
APH lost 2.55% ($2.23) versus the prior close of $87.55, last trading at $85.32 on 1.3× average volume.
When is Amphenol Corporation's next earnings date?
APH's next earnings report is estimated for 2026-10-28 — about 20 days away.
What is the analyst price target for APH?
The consensus analyst price target for APH is $144.57, about 69.4% above the current $85.32. Over the past 90 days, analysts recorded 0 upgrades, 12 maintains, and 0 downgrades.
How BestStocks tracks APH
This page is generated automatically by BestStocks' change-detection system after a new SEC filing was detected and verified against independent data sources. It draws on 20 tracked change events for APH, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of October 8, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.